Haggerty J J, Evans D L, Golden R N, Pedersen C A, Simon J S, Nemeroff C B
Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill 27514.
Biol Psychiatry. 1990 Jan 1;27(1):51-60. doi: 10.1016/0006-3223(90)90019-x.
We determined the frequency of antithyroglobulin and antimicrosomal antibodies in 173 consecutively admitted psychiatric inpatients. (We found antithyroid antibodies in 8% (5/65) of patients with DSM-III major depression, 13% (4/31) with biploar disorder, and in 0% (0/4) of those with schizoaffective disorder.) The rate of antibody occurrence was unrelated to lithium exposure either within individual diagnostic categories or for the sample as a whole. The overall frequency of positive antithyroid antibody titers in patients with DSM-III affective disorder, 9% (9/99), did not differ from that in patients with nonaffective disorders, 10% (7/68). However, patients with bipolar affective disorder-mixed or bipolar affective disorder-depressed had a higher rate of positive antithyroid antibody titers than other patients. Our findings confirm earlier reports that thyroid disorders may be particularly common in patients with bipolar affective disorder, even in the absence of lithium exposure. However, as antithyroid antibodies also occurred at a relatively high rate in nonaffective disorders, the possible psychiatric effects of autoimmune thyroiditis do not appear to be limited to affective dysregulation.
我们测定了173名连续收治的精神科住院患者抗甲状腺球蛋白抗体和抗微粒体抗体的出现频率。(我们发现在DSM-III重度抑郁症患者中有8%(5/65)、双相情感障碍患者中有13%(4/31)存在抗甲状腺抗体,而精神分裂症伴情感障碍患者中抗体出现率为0%(0/4)。)在各个诊断类别中以及就整个样本而言,抗体出现率与锂暴露均无关。DSM-III情感障碍患者中抗甲状腺抗体滴度呈阳性的总体频率为9%(9/99),与非情感障碍患者的10%(7/68)并无差异。然而,双相情感障碍-混合型或双相情感障碍-抑郁型患者抗甲状腺抗体滴度呈阳性的比例高于其他患者。我们的研究结果证实了早期的报告,即甲状腺疾病在双相情感障碍患者中可能尤为常见,即使不存在锂暴露情况。然而,由于抗甲状腺抗体在非情感障碍患者中也有相对较高的出现率,自身免疫性甲状腺炎可能产生的精神影响似乎并不局限于情感失调。